NeurosciencebioRxivPreprint
ADAM10 pharmacological inhibition modifies the expression of components of the dopaminergic system
Subhamita Maitra, Bruno Vincent
This study shows that ADAM10 inhibition reduces dopamine receptor D4 levels and increases dopamine-degrading enzyme expression in neuroblastoma cells, suggesting a potential role in Alzheimer's disease psychosis.
DOI 10.1101/2022.05.26.493662